InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Trading Halt 3 Sep 2009 9:51AM $0.240 $0.010 fallen by 95.83%
- Preliminary Final Report - Appendix 4E 28 Aug 2009 10:08AM $0.260 $0.010 fallen by 96.15%
- Appendix 4C - quarterly 29 Jul 2009 1:50PM $0.250 $0.010 fallen by 96%
- Open Briefing - BNO CEO on Milestones Achieved 2 Jul 2009 11:06AM $0.220 $0.010 fallen by 95.45%
- BNO - US Clinical Trial of BNC105 in Renal Cell Cancer 2 Jul 2009 9:22AM $0.220 $0.010 fallen by 95.45%
- BNC210 Phase I Clinical Trial Initiated 25 Jun 2009 9:27AM $0.230 $0.010 fallen by 95.65%
- Open Briefing BNC105 Interim Data 29 May 2009 10:54AM $0.255 $0.010 fallen by 96.08%
- Initial Data from BNC105 Phase I Clinical Trial Presented 29 May 2009 9:17AM $0.255 $0.010 fallen by 96.08%
- BNO Anxiety Drug Candidate Approved to Enter Human Trial 21 May 2009 9:40AM $0.250 $0.010 fallen by 96%
- Open Briefing - New Data on BNC105 22 Apr 2009 12:03PM $0.250 $0.010 fallen by 96%
- New BNC105 Data Presented at AACR Conference 22 Apr 2009 8:55AM $0.250 $0.010 fallen by 96%
- Appendix 4C - quarterly 15 Apr 2009 3:23PM $0.200 $0.010 fallen by 95%
- Half Yearly Report and Accounts 25 Feb 2009 2:32PM $0.200 $0.010 fallen by 95%
- Key Institutional Investor Supports BNO Capital Raising 10 Feb 2009 11:00AM $0.210 $0.010 fallen by 95.24%
- BNO - Open Briefing 5 Feb 2009 10:47AM $0.180 $0.010 fallen by 94.44%
- Appendix 4C - quarterly 30 Jan 2009 12:58PM $0.190 $0.010 fallen by 94.74%
- Open Briefing - CEO on Update 15 Jan 2009 9:36AM $0.225 $0.010 fallen by 95.56%
- BNC210 Successfully Completes Safety Studies 17 Dec 2008 11:00AM $0.230 $0.010 fallen by 95.65%
- Bionomics - Options Underwriting 16 Dec 2008 12:36PM $0.210 $0.010 fallen by 95.24%
- Open Briefing - BNO CEO on Recent Developments 12 Nov 2008 9:38AM n/a $0.010 n/a
- Austin Health Comes On Board BNC105 Trial 5 Nov 2008 8:43AM $0.290 $0.010 fallen by 96.55%
- BNO - Appendix 4C 31 Oct 2008 10:08AM $0.290 $0.010 fallen by 96.55%
- BNC105 Clinical Trial Update 16 Sep 2008 11:54AM $0.325 $0.010 fallen by 96.92%
- BNC210 Decreases Anxiety in Animal Models 1 Sep 2008 9:32AM $0.350 $0.010 fallen by 97.14%
- BNO 07/08 Preliminary Final Results 22 Aug 2008 9:44AM n/a $0.010 n/a

676 - 700 of 801 results

Page 28 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.